Related Experiment Video
Updated: May 22, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Incontinence-associated dermatitis: consensus statements, evidence-based guidelines for prevention and treatment, and
Dorothy Doughty1, Joan Junkin, Peter Kurz
1WOC Nursing Education Center, Emory University, Atlanta, Georgia 30322, USA. ddought@emory.edu
Summary
Incontinence-associated dermatitis (IAD) is distinct from other skin conditions. Structured skin care programs effectively prevent and manage IAD, though differentiating it remains challenging.
Area of Science:
- Dermatology
- Gerontology
- Nursing
Background:
- Incontinence-associated dermatitis (IAD) is a common issue in patient care.
- Previous literature reviews informed current understanding of IAD.
- An international consensus conference addressed IAD pathology, prevention, and management.
Purpose of the Study:
- To summarize key consensus statements on IAD.
- To present evidence-based guidelines for IAD prevention and management.
- To discuss challenges faced by clinicians in managing IAD.
Main Methods:
- Literature review and synthesis of evidence.
- International consensus conference with expert panelists.
- Discussion of clinical challenges and recommendations.
Main Results:
- Incontinence-associated dermatitis (IAD) is pathologically distinct from pressure ulcers and intertriginous dermatitis.
- Consistently applied, structured skin care programs are effective for IAD prevention and management.
- Differential assessment of IAD versus other skin conditions presents a significant clinical challenge.
Conclusions:
- While structured skin care is effective, evidence gaps exist regarding optimal products and protocols for IAD.
- Improved differential assessment, product labeling, staff education, and cost-effectiveness are crucial for IAD management.
- Addressing these challenges is essential for improving patient outcomes and care quality.
Related Concept Videos
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:17Urinary Tract Infection IV: Nursing Management
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...